Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Plos One
|
December 20, 2012
The value of source data verification in a cancer clinical trial
Catrin Tudur Smith, Deborah D Stocken, Janet Dunn, et al.
British Journal of Cancer
|
March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, William Greenhalf, Eithne Costello, et al.
BMC Medical Research Methodology
|
April 9, 2025
Estimating treatment effects using parametric models as counter-factual evidence
Richard Jackson, Philip Johnson, Sarah Berhane, et al.
Molecular Cancer
|
June 3, 2014
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
Victoria E Shaw, Brian Lane, Claire Jenkinson, et al.
Critical Care (London, England)
|
March 20, 2013
Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis
Alison M Hall, Lee A L Poole, Bryan Renton, et al.
Trends in Hearing
|
January 30, 2026
The First Cadenza Challenge: Perceptual Evaluation of Machine Learning Systems to Improve Audio Quality of Popular Music for Those with Hearing Loss
Scott Bannister, Jennifer Firth, Gerardo Roa-Dabike, et al.
Trials
|
January 15, 2016
The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial
Lisa Loughney, Malcolm A West, Graham J Kemp, et al.
British Journal of Cancer
|
September 2, 2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
Jörg Kleeff, Eithne Costello, Richard Jackson, et al.
Gut
|
June 22, 2016
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Paola Martinelli, Enrique Carrillo-de Santa Pau, Trevor Cox, et al.
Perioperative Medicine (London, England)
|
December 3, 2025
Correction: The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial)
Lisa Loughney, Malcolm A West, Helen Moyses, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Plos One
|
December 20, 2012
The value of source data verification in a cancer clinical trial
Catrin Tudur Smith, Deborah D Stocken, Janet Dunn, et al.
British Journal of Cancer
|
March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, William Greenhalf, Eithne Costello, et al.
BMC Medical Research Methodology
|
April 9, 2025
Estimating treatment effects using parametric models as counter-factual evidence
Richard Jackson, Philip Johnson, Sarah Berhane, et al.
Molecular Cancer
|
June 3, 2014
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
Victoria E Shaw, Brian Lane, Claire Jenkinson, et al.
Critical Care (London, England)
|
March 20, 2013
Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis
Alison M Hall, Lee A L Poole, Bryan Renton, et al.
Trends in Hearing
|
January 30, 2026
The First Cadenza Challenge: Perceptual Evaluation of Machine Learning Systems to Improve Audio Quality of Popular Music for Those with Hearing Loss
Scott Bannister, Jennifer Firth, Gerardo Roa-Dabike, et al.
Trials
|
January 15, 2016
The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial
Lisa Loughney, Malcolm A West, Graham J Kemp, et al.
British Journal of Cancer
|
September 2, 2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
Jörg Kleeff, Eithne Costello, Richard Jackson, et al.
Gut
|
June 22, 2016
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Paola Martinelli, Enrique Carrillo-de Santa Pau, Trevor Cox, et al.
Perioperative Medicine (London, England)
|
December 3, 2025
Correction: The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial)
Lisa Loughney, Malcolm A West, Helen Moyses, et al.
Page
of 3